Home > BSX Analysis

Is Boston Scientific Corporation (BSX) Undervalued?

Based on the current stock price of $96.06 and a P/E ratio of 51.37,Boston Scientific Corporation has a PEG ratio of 2.46.

The Short Answer:

Most analysts consider a PEG ratio below 1.0 to be undervalued. With a ratio of 2.46, BSX appears to be potentially overvalued relative to its growth rate of 20.87%.

Valuation Status
Overvalued

Based on a PEG ratio of 2.46 (adjusted for dividends).

01.02.0+
P/E Ratio
51.37
Growth Rate
20.87%
Stock Price
$96.06
Market Cap
142403371008

Compare BSX vs Competitors

Use the calculator below to see how BSX stacks up against other stocks in the same industry.

Analyze Any Stock

Get instant P/E, PEG, and PEGY ratios with real-time data

💡 Try popular stocks: AAPL, MSFT, GOOGL, TSLA, AMZN, NVDA, META

How we analyzed BSX

We calculated the PEG (Price/Earnings-to-Growth) ratio by taking the Price-to-Earnings Ratio of 51.37and dividing it by the annual growth rate of 20.87%.

PEG = 51.37 (P/E) ÷ 20.87 (Growth) = 2.46

Frequently Asked Questions about BSX

What is the current PEG Ratio for Boston Scientific Corporation (BSX)?+

The current PEG Ratio for Boston Scientific Corporation is 2.46. A PEG ratio below 1.0 generally suggests the stock may be undervalued relative to its growth.

Is BSX stock undervalued right now?+

Based on the PEG ratio of 2.46, Boston Scientific Corporation appears to be potentially overvalued. Investors typically look for a PEG ratio below 1.0 to find undervalued growth stocks.

What is the PEGY Ratio for BSX?+

The PEGY ratio for Boston Scientific Corporation is 2.46. This metric accounts for dividend yield (0.00%), providing a more complete valuation picture.